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HO1Hyperammonemia induces signiﬁcant changes in the central nervous system (CNS) in direct association
with astroglial functions, such as oxidative damage, glutamatergic excitotoxicity, and impaired glutamine
synthetase (GS) activity and pro-inﬂammatory cytokine release. Classically, lipoic acid (LA) and
N-acetylcysteine (NAC) exhibit antioxidant and anti-inﬂammatory activities by increasing glutathione
(GSH) biosynthesis and decreasing pro-inﬂammatory mediator levels in glial cells. Thus, we evaluated
the protective effects of LA and NAC against ammonia cytotoxicity in C6 astroglial cells. Ammonia
decreased GSH levels and increased cytokine release and NFjB transcriptional activation. LA and NAC
prevented these effects by the modulation of ERK and HO1 pathways. Taken together, these observations
show that LA and NAC prevent the ammonia-induced inﬂammatory response.
 2015 Elsevier Ltd. All rights reserved.1. Introduction
Ammonia is a key factor in the pathogenesis of hepatic
encephalopathy (HE), which is a major complication in acute and
chronic liver failure (Felipo and Butterworth, 2002; Gorg et al.,
2010). Hyperammonemia induces strong metabolic effects in the
central nervous system (CNS), and astrocytes have a critical func-
tion in the detoxiﬁcation of ammonia, due the presence of the
enzyme glutamine synthetase (GS) (Felipo and Butterworth, 2002).
Additionally, astrocytes contribute to maintenance of synaptic
information processing and ionic homeostasis; regulate energy
metabolism; control the biosynthesis of antioxidant defenses, like
glutathione (GSH); and modulate chemokine and cytokine release
(Belanger et al., 2011; Dringen, 2000; Farina et al., 2007; Maragakis
and Rothstein, 2006; Parpura et al., 2012; Pope et al., 2008;
Ransom and Ransom, 2012). In line with this, ammonia toxicity
triggers several changes in glial parameters, including reductionsin GS activity, glutamate transporters and the redox state, and it
also induces pro-inﬂammatory cytokine release (Bobermin et al.,
2012, 2013; Gorg et al., 2010; Hillmann et al., 2008; Jayakumar
et al., 2006; Leite et al., 2006; Norenberg, 2003; Norenberg et al.,
1997, 2009). Furthermore, classical changes in oxidative and
inﬂammatory activities induced by ammonia are associated with
the transcriptional activity of nuclear factor jB (NFjB) and extra-
cellular signal-regulated kinase (ERK) (Norenberg et al., 2009).
Our group has reported the beneﬁcial effects of antioxidants,
such as resveratrol and lipoic acid (LA), on glial cells and has also
proposed several mechanisms for their activities (Bobermin et al.,
2012, 2013; Kleinkauf-Rocha et al., 2013; Quincozes-Santos et al.,
2013, 2014; Quincozes-Santos and Gottfried, 2011). LA is an essen-
tial cofactor for mitochondrial enzymes and has been widely stud-
ied as a neuroprotective compound when exogenously
administered (Packer and Cadenas, 2011; Perera et al., 2011;
Salinthone et al., 2011). A variety of studies from cell cultures to
animal models have demonstrated that LA exhibits antioxidant
and anti-inﬂammatory activities by increasing GSH biosynthesis
and decreasing levels of pro-inﬂammatory mediators
(Rocamonde et al., 2013, 2012; Xia et al., 2014). Recently, we have
demonstrated that LA protects astroglial cells against ammonia
toxicity, thereby improving glutamatergic metabolism (Bobermin
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LA are complex and remain unclear.
N-acetylcysteine (NAC), a classical antioxidant, has been clini-
cally used for the treatment of several peripheral and brain disor-
ders (Berk et al., 2012; Samuni et al., 2013). Moreover, NAC can
sustain the synthesis of GSH because it is the acetylated precursor
of the amino acid cysteine, a constituent of tripeptide GSH, which
is the major antioxidant defense of the CNS (Beloosesky et al.,
2012; Reliene et al., 2009; Samuni et al., 2013). Although an
increase in intracellular GSH is commonly associated with beneﬁ-
cial activities of NAC, the GSH-independent mechanisms underly-
ing its activities are only partially understood.
The C6 cells are widely used as an astrocyte-like cell line to
study glial parameters and signaling pathways responsive to
effects of redox-active compounds and/or cytotoxic agents.
Therefore, the aim of this study was to evaluate the effects of
ammonia on GSH content and cytokine release in C6 astroglial cells
as well as the putative mechanisms involved in the cytoprotective
effects of LA and NAC against hyperammonemia. In this sense,
heme oxygenase 1 (HO1) has been reported to be involved in
potential intracellular pathway that provides cytoprotection
against stressful conditions, such as oxidative stress and inﬂamma-
tion (Bastianetto and Quirion, 2010; Sakata et al., 2010). Thus, the
following astroglial parameters were assessed: GSH content,
TNF-a, IL-1b, IL-6, IL-18, S100B, monocyte chemotactic protein 1
(MCP-1) and NFjB activation levels, nitric oxide (NO) production
and the roles of the ERK and HO1 pathways.2. Materials and methods
2.1. Materials
Lipoic acid (LA), N-acetylcysteine (NAC), PD98059, Zinc proto-
porphyrin (ZnPP IX), 1400W dihydrochloride, aminoguanidine
hydrochloride, standard GSH, o-phthaldialdeyde, monoclonal
anti-S100B antibody (SH-B1) and o-phenylenediamine (OPD) were
purchased from Sigma (St. Louis, MO, USA). Dulbecco’s Eagle’s
medium (DMEM), fetal bovine serum (FBS) and other materials
for cell culture were purchased from Gibco (Carlsbad, CA, USA).
Polyclonal Rabbit Anti-S100 was obtained from Dako (Glostrup,
Denmark) and Anti-rabbit IgG Horseradish Peroxidase from
Amersham (Buckingamshire, UK). ELISA kits were purchased from
PeproTech (Rocky Hill, NJ, USA) for TNF-a; eBioscience (San Diego,
CA, USA) for IL-1b, IL-6, IL-18 and MCP-1; Invitrogen (Carlsbad, CA,
USA) for NFjB p65. All other chemicals were obtained from com-
mon commercial suppliers.2.2. C6 astroglial cell culture and treatments
C6 astroglial cell line was obtained from the American Type
Culture Collection (Rockville, MD, USA) and was cultured according
to a previously described procedure (dos Santos et al., 2006). The
cells were seeded in ﬂasks and maintained in culture in DMEM
(pH 7.4) containing 5% fetal bovine serum (FBS), 0.1% amphotericin
B and 0.032% gentamicin. Cells were kept at a temperature of 37 C
in an atmosphere of 5% CO2/95% air. Exponentially growing cells
were detached from the culture ﬂasks using 0.05% trypsin/ethyle
ne-diaminetetracetic acid (EDTA) and seeded in 24-well plates
(5  103 cells/cm2).
At conﬂuence, the culture medium was removed by suction,
and the cells were pre-treated for 1 h with LA (10 lM) or NAC
(100 lM) at 37 C in an atmosphere of 5% CO2/95% air in DMEM
without serum. Subsequently, 5 mM ammonia (as ammonium
chloride  NH4Cl) was added in the presence or absence of LA or
NAC, for 24 h. To study the role of the ERK and HO1 on the effectsof LA and NAC, cells were pre-treated for 1 h (before ammonia and
LA/NAC treatments) with 5 lM PD98059 (a speciﬁc MEK/ERK inhi-
bitor) or 10 lM ZnPP IX (a speciﬁc HO1 inhibitor). Moreover, to
verify the role of nitric oxide synthase (NOS), cells were
pre-treated for 1 h with 1400W dihydrochloride (2 lM) or
aminoguanidine (250 lM). NH4Cl, NAC and aminoguanidine were
solubilized in water. LA, PD98059, ZnPP IX and 1400W dihy-
drochloride were solubilized in DMSO (ﬁnal concentration:
0.25%). For all parameters analyzed, the results obtained with vehi-
cle were not different from those obtained under basal conditions.
2.3. Membrane integrity and metabolic activity assays
2.3.1. Propidium iodide (PI) incorporation assay
Cells were treated simultaneously with 7.5 lM PI for up to 24 h.
The optical density of ﬂuorescent nuclei (labeled with PI), indica-
tive of cell death, was determined with Optiquant software
(Packard Instrument Company). Density values obtained are
expressed as percentage relative to the control values (Bobermin
et al., 2012).
2.3.2. MTT reduction assay
MTT was added to the medium at a concentration of 50 lg/mL
and cells were incubated for 30 min at 37 C in an atmosphere of
5% CO2/95% air (Bobermin et al., 2012). Subsequently, the medium
was removed and the MTT crystals were dissolved in DMSO.
Absorbance values were measured at 560 and 650 nm. The results
are expressed as percentages relative to the control values.
2.4. Glutathione (GSH) levels
GSH levels were assessed as previously described with some
modiﬁcations (Browne and Armstrong, 1998). C6 astroglial cells
were homogenate in 100 mM sodium phosphate buffer with
140 mM KCl (pH 8.0) containing 5 mM EDTA and the protein was
precipitated with 1.7% meta-phosphoric acid. Supernatant was
assayed with o-phthaldialdeyde (at a concentration of 1 mg/mL
methanol) at room temperature for 15 min. Fluorescence was mea-
sured using excitation and emission wavelengths of 350 and
420 nm, respectively (Spectra Max GEMINI XPS, Molecular
Devices, USA). A calibration curve was performed with standard
GSH solutions at concentration ranging from 0 lM to 500 lM.
GSH concentrations were calculated as nmol/mg protein and
expressed as percentages relative to the control values.
2.5. S100B measurement
S100B secretion was measured by an enzyme-linked immune
sorbent assay, as previously described (Leite et al., 2008). Brieﬂy,
50 lL of sample (culture medium) and 50 lL of Tris buffer
(50 mM, pH 8.6) were incubated for 2 h on a microtiter plate pre-
viously coated overnight at 4 C with a fresh 1:1000 dilution of
monoclonal anti-S100B (SH-B1) in 50 mM carbonate-bicarbonate
buffer (pH 9.5). Next, the samples were incubated with polyclonal
anti-S100B (diluted 1:5000) for 30 min, and then,
peroxidase-conjugated anti-rabbit antibody (1:5000) was added
for a further 30 min incubation period at 37 C. A colorimetric reac-
tion with o-phenylenediamine was observed at 492 nm. A calibra-
tion curve was performed with standard S100B at concentration
ranging from 0.019 to 10 ng/mL. The results are expressed as per-
centages relative to the control levels.
2.6. Cytokines measurement
The levels of cytokines were carried out in the culture medium
(50 lL), using ELISA kits for TNF-a (PeproTech, Rocky Hill, NJ, USA),
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lowing the manufacturers’ instructions. The results are expressed
as the percentages relative to the control levels.
2.7. Nuclear factor-kB levels
The levels of NFjB p65 in the nuclear fraction, which had been
isolated from lysed cells by centrifugation, were measured using an
ELISA commercial kit from Invitrogen (Carlsbad, CA, USA). The
results are expressed as percentages relative to the control levels.
2.8. Nitrite levels
NO production was determined by measuring the amount of
nitrite (a stable oxidation product of NO), as indicated by the
Griess reaction. The Griess reagent was prepared by mixing equal
volumes of 1% sulfanilamide in 0.5 M HCl and 0.1%
N-(1-naphthyl) ethylenediamine in deionized water. Brieﬂy, the
Griess reagent was added directly to the cell culture, which was
incubated in the dark for 15 min at room temperature
(Quincozes-Santos et al., 2013). Samples were analyzed at
550 nm on a microplate spectrophotometer. Nitrite concentrations
were calculated using a standard curve prepared with concentra-
tions of sodium nitrite ranging from 0 to 50 lM. The results are
expressed as percentages relative to the control levels.
2.9. Protein determination
Protein content was measured by Lowry’s method using bovine
serum albumin as standard (Lowry et al., 1951).
2.10. Statistical analysis
Differences among groups were statistically analyzed using
two-way analysis of variance (ANOVA), followed by Tukey’s test.
All analyses were performed using the Statistical Package for
Social Sciences (SPSS) software, version 16.0 (SPSS Inc., Chicago,
IL, USA).Fig. 2. Effects of LA and NAC on ammonia-induced GSH decrease. Cells were
incubated for 1 h with LA (10 lM) or NAC (100 lM), followed by the addition of
5 mM ammonia for 24 h in serum-free DMEM. Data represent the mean ± S.E.M of
four independent experimental determinations performed in triplicate and differ-
ences among groups were statistically analyzed using two-way ANOVA, followed by
Tukey’s test. The absolute value obtained in the control conditions for GSH levels
were 15 ± 0.8 nmol/mg protein. Values of P < 0.05 were considered signiﬁcant. a
indicates differences from control conditions and b differences from ammonia
exposure.3. Results
3.1. Changes in cellular morphology and membrane integrity after
ammonia, LA and NAC treatments
Classically, ammonia exposure induces changes in glial mor-
phology after the ﬁrst 6 h of incubation (Leite et al., 2006). Here,
we showed that at 24 h these changes are not signiﬁcant
(Fig. 1A and B). We also showed that LA and NAC did not modifyFig. 1. Cellular morphology after ammonia, LA and NAC treatments. C6 astroglial cells w
5 mM ammonia for 24 h in serum-free DMEM. The cells present polygonal morphology, a
plus LA (C) and ammonia plus NAC (D). Representative images of three experiments pecellular morphology (Fig. 1C and D). With regard to cellular integ-
rity, we did not observe changes in propidium iodide (PI) incorpo-
ration or MTT reduction following the ammonia, LA or NAC
treatments (data not shown).
3.2. LA and NAC prevented ammonia-induced GSH decrease
Ammonia decreased GSH levels by approximately 25% com-
pared with the control conditions (Fig. 2). LA and NAC restored
the GSH intracellular levels to near the basal. Moreover, LA and
NAC per se increased GSH levels, by 30% and 70%, respectively.
3.3. LA and NAC prevented ammonia-induced TNF-a, IL-1b, IL-6, IL-18,
S100B and MCP-1 release through ERK and HO1 pathways
Ammonia induced signiﬁcant release in the levels of TNF-a
(50%, Fig. 3A), IL-1b (35%, Fig. 3B), IL-6 (35%, Fig. 3C), IL-18 (30%,
Fig. 3D), S100B (55%, Fig. 3E) and MCP-1 (30%, Fig. 3F). Because
changes in cell integrity were not observed, the increased levels
observed in cytokines most likely resulted from secretion.
LA and NAC prevented all of these changes. LA and NAC per se
did not affect cytokine release. To test the involvement of ERK
and HO1 in the effect of LA and NAC, speciﬁc inhibitors of these sig-
naling pathways were used. The incubation of cells with an ERKere incubated for 1 h with LA (10 lM) or NAC (100 lM), followed by the addition of
s shown by phase contrast microscopy. Basal conditions (A), ammonia (B), ammonia
rformed in triplicate. Scale bar = 50 lm.
Fig. 3. Effects of LA and NAC on cytokines and S100B release. Cells were incubated for 1 h with LA (10 lM) or NAC (100 lM), followed by the addition of 5 mM ammonia for
24 h in serum-free DMEM. 5 lM PD98059 or 10 lM ZnPP IX were co-incubated with LA and NAC. TNF-a (A), IL-1b (B), IL-6 (C), IL-18 (D), S100B (E) and MCP-1 (F) release were
measured. Data represent the mean ± S.E.M of four independent experimental determinations performed in triplicate and differences among groups were statistically
analyzed using two-way ANOVA, followed by Tukey’s test. Values of P < 0.05 were considered signiﬁcant. a indicates differences from control conditions and b differences
from ammonia exposure.
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LA and NAC, decreasing the augmented cytokines to levels lower
than those observed with ammonia plus LA or NAC (Fig. 3A–F).
Furthermore, Fig. 3 also displays that HO1 inhibitor (ZnPP IX) com-
pletely abolished the effects of LA and NAC. It is important to men-
tion that both inhibitors had no effect per se.3.4. LA and NAC inhibited ammonia-stimulated NFjB activation
through ERK and HO1 signaling pathways
To elucidate the possible mechanisms of the inhibition of the
inﬂammatory response by LA and NAC, we examined NFjB activa-
tion. Ammonia increased the NFjB p65 levels by 45% (Fig. 4), and
LA and NAC decreased the NFjB levels from 145% to 110% and
112%, respectively. The antioxidants per se did not alter the tran-
scriptional activity of NFjB. ERK inhibitor increased the effects ofLA and NAC on ammonia-induced NFjB activation. The HO1 inhi-
bitor also completely abolished the effects of LA and NAC. ERK
and HO1 inhibitors had no effect per se.3.5. LA and NAC prevented ammonia-induced NO production
NO production was indirectly measured by the formation of
nitrite (Fig. 5). Ammonia increased nitrite levels by approximately
29% compared with the control conditions. This effect was pre-
vented by LA and NAC. Moreover, both LA and NAC per se
decreased NO production, 23% and 20%, respectively.
Additionally, we evaluated the effect of the HO1 inhibitor (ZNPP
IX) and NOS inhibitors (1400W dihydrochloride and aminoguani-
dine) on NO production. The 1400W dihydrochloride and
aminoguanidine per se decreased nitrite levels (35% and 20%,
respectively), but ZNPP IX did not. When coincubated with
Fig. 4. LA and NAC prevented ammonia-stimulated NFjB activation levels. Cells
were incubated for 1 h with LA (10 lM) or NAC (100 lM), followed by the addition
of 5 mM ammonia for 24 h in serum-free DMEM. 5 lM PD98059 or 10 lM ZnPP IX
were coincubated with LA and NAC. Data represent the mean ± S.E.M of four
independent experimental determinations performed in triplicate and differences
among groups were statistically analyzed using two-way ANOVA, followed by
Tukey’s test. Values of P < 0.05 were considered signiﬁcant. a indicates differences
from control conditions and b differences from ammonia exposure.
Fig. 5. Effects of LA and NAC on NO production. Cells were incubated for 1 h with LA
(10 lM) or NAC (100 lM), followed by the addition of 5 mM ammonia for 24 h in
serum-free DMEM. 10 lM ZnPP IX, 2 lM 1400W dihydrochloride or 250 lM
aminoguanidine were coincubated with ammonia, LA and NAC. Data represent the
mean ± S.E.M of three independent experimental determinations performed in
triplicate and differences among groups were statistically analyzed using two-way
ANOVA, followed by Tukey’s test. Values of P < 0.05 were considered signiﬁcant. a
indicates differences from control conditions and b differences from ammonia
exposure.
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duction. However, HO1 inhibitor, and not NOS inhibitors, blocked
the effects of LA and NAC on ammonia-induced NO production,
indicating that these protective effects are closely related to HO1
pathway.4. Discussion
The results of this study showed that LA and NAC protected
astroglial cells against ammonia-induced cytotoxicity. Ammonia
decreased GSH levels and induced NFjB activation with conse-
quent increases in pro-inﬂammatory cytokines and S100B secre-
tion. The protective effects of LA and NAC on glial cells involve
ERK and HO1 signaling pathways.
Ammonia is a key element in the pathogenesis of HE, which is a
complex neurological disorder, manifested by low-grade cerebral
edema associated with oxidative/nitrosative stress and inﬂamma-
tion (Bobermin et al., 2012; Gorg et al., 2015). Astrocytes have a
critical role in the pathogenesis of HE and studies in cultured astro-
cytes indicate that ammonia induces morphological alterations
and osmotic swelling, in a reversible manner (Gorg et al., 2013;
Leite et al., 2006). In this sense, ammonia did not induce morpho-
logical changes in C6 astroglial cells after 24 h of treatment (Fig. 1),
but signiﬁcant alterations were observed in the ﬁrst hours of expo-
sure, followed of return to normal cell morphology with curse of
time.
Classically, ammonia also results in changes in intracellular pH
in all cell types, including astrocytes (Haack et al., 2014; Rose et al.,
2005). To test whether ammonia effects observed in the present
work were dependent of alterations in intracellular pH, we incu-
bated C6 cells with the weak base trimethylamine (TMA, 10 lM),
an established tool to manipulate intracellular pH. However, TMA
did not modify the cellular viability, GSH levels and inﬂammatory
response after 24 h of treatment (data not shown). This data sug-
gest that the cytotoxicity was a speciﬁc consequence of ammonia.The antioxidative effects of LA and NAC were supported by the
modulation of the GSH homeostasis (Packer and Cadenas, 2011;
Rocamonde et al., 2012; Samuni et al., 2013). Thereby, recently,
Badisa et al. showed that NAC prevented cocaine-induced toxicity
in astroglia-like cells through an increase in GSH levels (Badisa
et al., 2015). As astroglial cells contain the highest concentrations
of GSH in the brain, they play an important role in the protection
of oxidative damage (Belanger et al., 2011; Dringen, 2000). In line
with this, the increase of GSH levels in glial cells confers protection
against neurological disorders, such as epilepsy, Alzheimer’s and
Parkinson’s diseases (Halliwell, 2006; Lee et al., 2010b). In this
sense, ammonia decreases the GSH levels and, in agreement with
other ﬁndings from our group, also induces oxidative and nitrosa-
tive stress and causes impairment of glutamate transporter activity
(Bobermin et al., 2012, 2013). Accordingly, the depletion of GSH in
glial cells induces neuroinﬂammation with signiﬁcant augmenta-
tion of pro-inﬂammatory cytokines (Lee et al., 2010b).
Furthermore, oxidative stress (in association with GSH depletion)
has been shown to play a critical role in the inﬂammatory
response, and the pathophysiology of brain disorders, such as HE,
involves oxidative and inﬂammatory pathways (Butterworth,
2011a,b; Norenberg, 2003).
Thus, herein, we demonstrated that ammonia stimulated
increases in the TNF-a, IL-1b, IL-6, IL-18 and MCP-1 levels. TNF-a
is synthesized mainly by glial cells and has several important func-
tions in the CNS, including astrocyte activation and glutamatergic
gliotransmission (Santello et al., 2011; Tanabe et al., 2010).
Additionally, TNF-a and IL-1b, which are classical
pro-inﬂammatory cytokines, play major roles in initiating a cas-
cade of activation of other cytokines, such as IL-6 and IL-18
(Tanabe et al., 2011, 2010). IL-6 is also produced by glial cells
and has a pivotal role in pathological brain inﬂammation as well
as IL-18, a member of IL-1 superfamily, which induces the inﬂam-
matory process and has been directly associated with neurodegen-
erative diseases (Bossu et al., 2010; de Rivero Vaccari et al., 2014).
Fig. 6. Schematic illustration of the protective effects of LA and NAC against ammonia-induced cytotoxicity. Ammonia decreased GSH levels and induced NFjB activation
with consequent increase in pro-inﬂammatory cytokines and S100B secretion. LA and NAC protected glial cells. Moreover, the ERK and HO1 signaling pathways participate in
the mechanisms of action of LA and NAC.
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tory neurotoxicity and can activate MAPK pathways in CNS
(Ramesh et al., 2013). Recent studies have shown that
pro-inﬂammatory cytokines are increased in patients with HE
and may be used as markers of encephalopathy grade
(Butterworth, 2011a). Assuming that S100B plays a role in neuroin-
ﬂammation, it exhibited the same proﬁle of pro-inﬂammatory
cytokines (Donato, 2001; Mrak and Grifﬁn, 2005). Moreover, ele-
vated serum levels of S100B have been observed in HE patients,
and our group has found the increased secretion of S100B in pri-
mary astrocytes and C6 cells (Bobermin et al., 2012, 2013; Leite
et al., 2006; Wiltfang et al., 1999).
LA and NAC strongly down-regulated ammonia-stimulated
cytokine release, reinforcing the anti-inﬂammatory activity of
these compounds. Previous works have reported that the protec-
tive effects of LA may result from decreases in the levels of
pro-inﬂammatory cytokines in in vitro and in vivo models of study
(Kim et al., 2014; Koriyama et al., 2013; Li et al., 2015; Scumpia
et al., 2014). Similarly, NAC is able to inhibit NFjB activation
and, consequently, attenuates the inﬂammatory response (Carroll
et al., 1998; Chen et al., 2008; Li et al., 2002; Thakurta et al.,
2012). Moreover, NAC has been identiﬁed as a multi-target acting
drug, with glutamatergic, antioxidant and anti-inﬂammatory prop-
erties (Samuni et al., 2013). NAC reduced pro-inﬂammatory cytoki-
nes after traumatic brain injury and focal brain ischemia in rats as
well as in burned patients (Chen et al., 2008; Csontos et al., 2012;
Samuni et al., 2013). Thus, the results observed here for LA and
NAC are consistent with other studies, indicating that they have
a therapeutic potential against ammonia toxicity.
NFjB is a transcriptional factor that is considered the major
inﬂammatory mediator in the CNS (Gloire et al., 2006). As
expected, treatment with ammonia increased NFjB activation,
and LA and NAC were able to inhibit the NFjB p65 levels. These
antioxidants have both been shown to suppress NFjB cascade sig-
naling and the subsequent production of pro-inﬂammatory cytoki-
nes (Packer and Cadenas, 2011; Samuni et al., 2013; Shay et al.,
2009). In this study, we focused on testing a mechanistic hypothe-
sis; speciﬁcally, whether the attenuation of pro-inﬂammatory
cytokines by antioxidants occurs through the ERK and HO1 signal-
ing pathways.
The ERK pathway has been implicated in the regulation of the
glial inﬂammatory response following insult, and is an upstream
signal transduction of NFjB (Bobermin et al., 2012; Lee et al.,2010a). Moreover, ERK is involved in the mechanisms of
ammonia-induced toxicity (Bobermin et al., 2012, 2013; Dai
et al., 2013; Norenberg et al., 2009). Here, we observed that the
translocation of p65 NFjB into to the nucleus and
pro-inﬂammatory cytokines release levels induced by ammonia
were dependent of ERK signaling. Furthermore, ERK inhibitor
increased the effects of LA and NAC, indicating that the attenuation
of signaling through this pathway may be involved in the
anti-inﬂammatory activities of LA and NAC.
Concerning to HO1, it is the rate-limiting enzyme in the path-
way through which pro-oxidant heme is degraded into the antiox-
idants biliverdin and bilirubin (Bastianetto and Quirion, 2010;
Dore, 2005; Wakabayashi et al., 2010b). Increases in HO1 activity
have been associated with protection against stressful conditions,
such as oxidative stress and inﬂammation, which commonly occur
in HE (Bastianetto and Quirion, 2010; Sakata et al., 2010). HO1,
through its transcription factor, Nrf2, mediates neuroprotection
by modulating several genes that encode antioxidant proteins,
such as the GSH system (Calkins et al., 2009; Vargas and
Johnson, 2009; Wakabayashi et al., 2010b). HO1 also facilitates
GSH synthesis by regulating EAAC1, the main glutamate trans-
porter in C6 cells (Escartin et al., 2011). Additionally, HO1 signaling
occurs upstream of NFjB signaling, impeding its translocation to
the nucleus (Wakabayashi et al., 2010b), and we found that the
copresence of HO1 inhibitor blocked the positive effects of LA
and NAC on NFjB activation in astroglial cells.
NFjB activation also stimulates NO production via iNOS expres-
sion, subsequently inducing pro-inﬂammatory cytokine release.
Moreover, excessive NO can become noxious, causing cellular
damage (Calabrese et al., 2007). Our data indicated that ammonia
increased NO production via iNOS activation, the main isoform
present in astroglial cells. However, LA and NAC prevented ammo-
nia–induced NO production through HO1 pathway. It is important
to note that there is a close and reciprocal interaction between
HO1 and iNOS/NO signaling systems. Excess of NO acts as a signal
to increase HO1 expression, which in turn, counteracts NO toxicity
by inhibiting iNOS activity and directly scavenging NO
(Quincozes-Santos et al., 2013; Wakabayashi et al., 2010a). We
demonstrated that LA and NAC decreased nitrite levels as well as
NFjB activation via the HO1 signaling pathway; thus, this inhibi-
tion may be associated with attenuation of the inﬂammatory
response and oxidative stress.
1356 C.L. Santos et al. / Toxicology in Vitro 29 (2015) 1350–1357Although ZnPP IX is classically used as HO1 inhibitor, it can also
inhibit NOS isoforms (Wolff et al., 1996). Thus, we tested NOS inhi-
bitors (1400W dihydrochloride and aminoguanidine) on NO pro-
duction, comparing their effects with those obtained from ZnPP
IX. Different of ZNPP IX, the treatments with 1400W dihydrochlo-
ride and aminoguanidine did not change the effects of LA and NAC
on NO levels. Thus, these results suggest that ZnPP IX acting pri-
marily as HO1 inhibitor in our experimental conditions and, there-
fore, reinforce that HO1, and not iNOS, is the primary mechanism
involved in the protective role of LA and NAC during ammonia
toxicity.
In summary, our data reinforce the antioxidant and
anti-inﬂammatory effects of LA and NAC on ammonia toxicity in
glial cells. Moreover, our ﬁndings show that the ERK and HO1 sig-
naling pathways participate in the mechanisms of action of LA and
NAC (Fig. 6). Notably, LA and NAC increase GSH, conferring protec-
tion against neuroinﬂammation, as has been shown in clinical tri-
als involving HE (Butterworth, 2011b; Samuni et al., 2013; Shay
et al., 2009). Thus, our results improve the understanding of the
glioprotection of LA and NAC against hyperammonemia. Studies
investigating the outcomes of LA and NAC in the in vivo hyperam-
monemia animal model are currently in progress in our lab, focus-
ing on glial properties.Conﬂict of Interest
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